Global Brain Health Devices Market Size By Type (Electroencephalogram (EEG), Computed Tomography (CT)), By Application (Epilepsy, Dementia), By Region, And Segment Forecasts, 2023 to 2032

The Global Brain Health Devices Market was valued at USD 10.4 billion in 2023 and is projected to reach USD 19.3 billion by 2031, expanding at a CAGR of 7.9% during the forecast period of 2023–2031. This growth is driven by the rising prevalence of neurological disorders, the increasing geriatric population, and advancements in neurotechnology. Brain health devices are critical in diagnosing, monitoring, and managing conditions such as Alzheimer’s disease, epilepsy, Parkinson’s disease, and depression. The growing focus on early detection and personalized treatment strategies is further propelling market demand.

Drivers:

1. Rising Prevalence of Neurological Disorders:

An increase in neurological disorders globally, including dementia and epilepsy, is significantly boosting the demand for brain health diagnostic and monitoring tools.

2. Technological Advancements in Neuroimaging and Wearables:

Continuous innovation in non-invasive neuroimaging devices, portable EEGs, and brain-computer interfaces is enhancing diagnosis accuracy and patient comfort.

3. Growing Geriatric Population:

With aging being a key risk factor for neurodegenerative diseases, the rising elderly population worldwide is contributing to the market's upward trajectory.

Restraints:

1. High Costs of Brain Health Devices:

The upfront and maintenance costs of advanced neurological monitoring equipment can limit adoption, particularly in low- and middle-income countries.

2. Stringent Regulatory Landscape:

The market is subject to rigorous regulatory approval processes, which can delay product launches and hinder innovation cycles.

Opportunity:

1. Expansion in Home-Based Neurodiagnostics:

The increasing adoption of home-based brain health monitoring devices creates growth avenues, especially for chronic care and remote patient monitoring.

2. Integration of AI and Machine Learning:

The application of AI for predictive analytics and personalized neurotherapy is expected to revolutionize how brain health conditions are diagnosed and treated.

Market by System Type Insights:

The Electroencephalography (EEG) Devices segment accounted for the largest market share in 2023. EEGs are widely used for their effectiveness in detecting electrical abnormalities in the brain and remain a staple diagnostic tool in neurology. However, the Neurofeedback Devices segment is projected to grow at the fastest rate, driven by its rising use in cognitive enhancement and behavioral therapy.

Market by End-use Insights:

Hospitals dominated the end-use segment in 2023, contributing more than 45% of total revenue. The availability of specialized diagnostic infrastructure and trained neurologists makes hospitals the primary point of use for brain health devices. However, Ambulatory Surgical Centers (ASCs) and Homecare settings are expected to witness significant growth, aligned with the increasing push for decentralized care models.

Market by Regional Insights:

North America led the global brain health devices market in 2023, attributed to its advanced healthcare infrastructure, rising cases of neurological conditions, and favorable reimbursement policies. Asia-Pacific is expected to register the fastest CAGR during the forecast period, bolstered by increasing healthcare investments, growing awareness, and an expanding patient pool in countries like India and China.

Competitive Scenario:

Key players operating in the Global Brain Health Devices Market include:

Medtronic plc

GE Healthcare

Natus Medical Incorporated

Nihon Kohden Corporation

Compumedics Limited

NeuroPace, Inc.

BrainScope Company, Inc.

EMOTIV Inc.

Advanced Brain Monitoring, Inc.

NeuroSky, Inc.

These companies are actively investing in R&D, strategic partnerships, and product innovations. For instance:

In 2023, Medtronic introduced a next-generation deep brain stimulation system designed to treat movement disorders with enhanced precision.

In 2024, NeuroPace partnered with a U.S.-based hospital network to expand access to its responsive neurostimulation (RNS) system for epilepsy patients.

In 2025, EMOTIV launched a consumer-grade EEG headset integrated with real-time cognitive monitoring applications.

Scope of Work – Global Brain Health Devices Market

Report Metric Details

Market Size (2023) USD 10.4 billion

Projected Market Size (2031) USD 19.3 billion

CAGR (2023–2031) 7.9%

Market Segments By System Type (EEG, MEG, MRI, etc.), By End-use (Hospitals, Homecare, ASCs)

Growth Drivers Aging population, rise in neurological disorders, tech innovation

Opportunities Home-based diagnostics, AI-powered brain health tools

Key Market Developments:

January 2023: GE Healthcare launched an AI-enabled brain MRI analysis platform, aiding in faster diagnosis of neurodegenerative conditions.

May 2024: BrainScope received FDA clearance for its mobile concussion assessment tool for emergency care applications.

March 2025: Compumedics signed a distribution agreement in Southeast Asia to expand its EEG and sleep diagnostic solutions in emerging markets.

FAQs:

1. What is the current market size of the Global Brain Health Devices Market?

The market was valued at USD 10.4 billion in 2023.

2. What is the major growth driver of the Global Brain Health Devices Market?

The primary growth driver is the rising prevalence of neurological disorders coupled with advancements in brain monitoring technology.

3. Which is the largest region during the forecast period in the Global Brain Health Devices Market?

North America is the largest regional market due to its advanced healthcare infrastructure and high disease prevalence.

4. Which segment accounted for the largest market share in the Global Brain Health Devices Market?

The EEG Devices segment held the largest share in 2023.

5. Who are the key market players in the Global Brain Health Devices Market?

Leading players include Medtronic, GE Healthcare, Natus Medical, Nihon Kohden, and NeuroPace.

Let me know if you'd like a visual dashboard or downloadable version of this report.